| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |